FDA Gives OK To Miss Some Drug Approval Deadlines
The U.S. Food and Drug Administration is allowing reviewers to miss some deadlines for approving new drug applications by up to two months in an effort to cope with staffing shortfalls...To view the full article, register now.
Already a subscriber? Click here to view full article